Holly Chapman
Family · New Braunfels, TXNPI 1730678103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,571 and has fallen 74.0% since, to $408 in 2024.
Across 133 payments — averaging $19.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$288
- Lilly USA, LLC$217
- Amgen$215
- Takeda Pharmaceuticals U.S.A., Inc.$208
- Medtronic$198
- Amarin Pharma, Inc.$193
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,620100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $288 |
| Lilly USA, LLC | 13 | $217 |
| Amgen | 10 | $215 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $208 |
| Medtronic | 4 | $198 |
| Amarin Pharma, Inc. | 14 | $193 |
| Biohaven Pharmaceuticals, Inc. | 7 | $183 |
| Novo Nordisk | 12 | $167 |
| Esperion Therapeutics, Inc. | 6 | $100 |
| Corium, LLC | 4 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Kowa Pharmaceuticals America, Inc. | 4 | $76 |
| GSK | 4 | $66 |
| AstraZeneca | 1 | $64 |
| Adlon Therapeutics L.p. | 3 | $60 |
| Pfizer | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Merck | 3 | $41 |
| Lundbeck LLC | 1 | $27 |
| Johnson & Johnson | 2 | $26 |
| Organogenesis Inc. | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Bausch Health US, LLC | 1 | $19 |
| Novartis | 1 | $17 |
| Organon | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| W. L. Gore & Associates, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Tris Pharma Inc | 1 | $13 |
| Medicure Pharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$117
- VRAYLAR$108
How this compares
$2,620 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 21 | $576 |
| Trazodone Hcl | 37 | $556 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $430 |
| Duloxetine Hcl | 12 | $355 |
| Omeprazole | 19 | $322 |
| Pantoprazole Sodium | 17 | $236 |
| Quetiapine Fumarate | 11 | $187 |
| Atorvastatin Calcium | 11 | $105 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $93 |
| Doxycycline Hyclate | 16 | $88 |
| Zolpidem Tartrate | 12 | $68 |
| Azithromycin | 12 | $39 |
| Cyclobenzaprine Hcl | 11 | $30 |
| Prednisone | 22 | $21 |
Paid to pharmacies, not to this prescriber.
Other family in New Braunfels
- Jeremy SchmidtNew Braunfels$132K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.